About Brinter
Advanced 3D BioPrinting Solutions
About Brinter
Advanced 3D BioPrinting Solutions
PROGRESSING BIOPRINTING
Brinter® is the culmination of years of 3D printing expertise and bio research.
Brinter® bioprinting company is the bioprinting branch of a Finnish 3D printing company, 3DTech Oy. We provide comprehensive 3D bioprinting solutions and services for pharmaceutical, biotechnological and cosmetic industries, universities, and research facilities. Brinter™ Bioprinters are always custom built for clients’ specific applications and needs.
PROGRESSING BIOPRINTING
Brinter® is the culmination of years of 3D printing expertise and bio research.

Brinter® bioprinting company is the bioprinting branch of a Finnish 3D printing company, 3DTech Oy. We provide comprehensive 3D bioprinting solutions and services for pharmaceutical, biotechnological and cosmetic industries, universities, and research facilities. Brinter™ Bioprinters are always custom built for clients’ specific applications and needs.
Mission
To put bioprinting within reach of every pharmaceutical company, hospital, university, and research center.
Vision
Improve worldwide health and save lives by advancing bioprinting technologies and increase its applicable uses.
Mission
To put bioprinting within reach of every pharmaceutical company, hospital, university, and research center.
Vision
Improve worldwide health and save lives by advancing bioprinting technologies and increase its applicable uses.
Core Team

Sanna Turunen
Product Manager

Tomi Kalpio
CEO and Co-Founder

Antti Arjonen
Head of Imaging and Cancer Protocols

Marko Piira
Head of Services

Pasi Kaskinen
Commercial Lead EMEA and APAC

Tomi Mikkonen
Lead Engineer
Advisory Board

Tomi Alapaattikoski
Chairman

Aki Luukkainen
Advisor

Ali Nasser
Advisor

Jarkko Suominen
Advisor
Core Team

Sanna Turunen
Product Manager

Tomi Kalpio
CEO and Co-Founder

Antti Arjonen
Head of Imaging and Cancer Protocols

Marko Piira
Head of Services

Pasi Kaskinen
Commercial Lead EMEA and APAC

Tomi Mikkonen
Lead Engineer
Advisory Board

Tomi Alapaattikoski
Chairman

Aki Luukkainen
Advisor

Ali Nasser
Advisor

Jarkko Suominen
Advisor
Streamlining Bio Applications
Current Technology
Currently, our Brinter® Bioprinter platform can be used in a variety of applications, such as a versatile tool for basic research in tissue engineering and regenerative medicine. 3D bioprinting solutions also offer a cost-effective approach to shorten and enhance the productivity of the drug discovery process. Bioprinted tissue models (e.g., liver) with multiple cell types and complex, native-like, physiological environment will eliminate the need for in vivo models during the drug discovery process. In addition, bioprinted liver models can also be used to assess hepatotoxicity and carcinogenicity of compounds, such as crop protection chemicals. Bioprinting can also be used to recapitulate the cancer microenvironment by precisely locating tumor cells and microcapillaries in a tumor tissue model to study cancer pathogenesis, growth, and metastasis.
Streamlining Bio Applications
Current Technology
Currently, our Brinter® Bioprinter platform can be used in a variety of applications, such as a versatile tool for basic research in tissue engineering and regenerative medicine. 3D bioprinting solutions also offer a cost-effective approach to shorten and enhance the productivity of the drug discovery process. Bioprinted tissue models (e.g., liver) with multiple cell types and complex, native-like, physiological environment will eliminate the need for in vivo models during the drug discovery process. In addition, bioprinted liver models can also be used to assess hepatotoxicity and carcinogenicity of compounds, such as crop protection chemicals. Bioprinting can also be used to recapitulate the cancer microenvironment by precisely locating tumor cells and microcapillaries in a tumor tissue model to study cancer pathogenesis, growth, and metastasis.
Advancing Bio Benefits
Future
The next new wave of personalized medicine will be customizable, patient-specific drugs. 3D bioprinting can tailor the geometry of a drug tablet to impact drug loading, release rate, and taste.
In the long run, our bioprinting technology will inspire solutions to address the shortage of organs for transplantation. Printing fully functional tissues and organs will become reality and enter clinical practice powered by advancements in biomaterials, bioprinting techniques and cell technology. Brinter™ is leading bioprinting companies in the quest for unlimited transplants.
Advancing Bio Benefits
Future
The next new wave of personalized medicine will be customizable, patient-specific drugs. 3D bioprinting can tailor the geometry of a drug tablet to impact drug loading, release rate, and taste.
In the long run, our bioprinting technology will inspire solutions to address the shortage of organs for transplantation. Printing fully functional tissues and organs will become reality and enter clinical practice powered by advancements in biomaterials, bioprinting techniques and cell technology. Brinter™ is leading bioprinting companies in the quest for unlimited transplants.
Our vision is to improve worldwide health and save lives by advancing bioprinting technology and increasing its applicable uses.
Our vision is to improve worldwide health and save lives by advancing bioprinting technology and increasing its applicable uses.
Global 3D Bioprinting Solutions Research Partners and Clients

Global 3D Bioprinting Solutions Research Partners and Clients

International Headquarters
International Headquarters
FINLAND
Itäinen Pitkäkatu 4C (PharmaCity)
20520 Turku, Finland
USA
2219 Main St
Santa Monica, CA 90405
Start innovating your bio sector today!
Revolutionary Modular 3D Bioprinting Solutions

Start innovating your bio sector today!
Revolutionary Modular 3D Bioprinting Solutions
